BAF60a-dependent chromatin remodeling preserves β cell function and contributes to the therapeutic benefits of GLP-1R agonists
Journal of Clinical Investigation · 01.12.2025 · 135 (23)
DOI: 10.1172/jci177980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.10.2025. Verfasst von Xinyuan Qiu und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Pathophysiology and Department of Hepatobiliary and Pancreatic Surgery of the Second Affiliated Hospital, Zhejiang Univer…. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Chromatin Assembly and Disassembly, Glucagon-Like Peptide-1 Receptor, Chromosomal Proteins, Non-Histone. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Fund for Excellent Young Scholars of China, National Key R&D Program of China, Shuguang Project.
Abstract (Originalsprache)
Impaired glucose-stimulated insulin secretion (GSIS) is a hallmark of β cell dysfunction in diabetes. Epigenetic mechanisms govern cellular glucose sensing and GSIS by β cells, but they remain incompletely defined. Here, we found that BAF60a functions as a chromatin regulator that sustains biphasic GSIS and preserves β cell function under metabolic stress conditions. BAF60a was downregulated in β cells from obese and diabetic mice, monkeys, and humans. β cell–specific inactivation of BAF60a in adult mice impaired GSIS, leading to hyperglycemia and glucose intolerance. Conversely, restoring BAF60a expression improved β cell function and systemic glucose homeostasis. Mechanistically, BAF60a physically interacted with Nkx6.1 to selectively modulate chromatin accessibility and transcriptional activity of target genes critical for GSIS coupling in islet β cells. A BAF60a V278M mutation associated with decreased β cell GSIS function was identified in human donors. Mice carrying this mutation, which disrupted the interaction between BAF60a and Nkx6.1, displayed β cell dysfunction and impaired glucose homeostasis. In addition, GLP-1R and GIPR expression was significantly reduced in BAF60a-deficient islets, attenuating the insulinotropic effect of GLP-1R agonists. Together, these findings support a role for BAF60a as a component of the epigenetic machinery that shapes the chromatin landscape in β cells critical for glucose sensing and insulin secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Pathophysiology and Department of Hepatobiliary and Pancreatic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Geriatrics, Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.
- College of Science and.
- College of Computer Science and Technology, National University of Defense Technology, Changsha, Hunan, China.
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
- Department of Hepatobiliary and Pancreatic Surgery of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Förderung
- Natural Science Fund for Excellent Young Scholars of China
- National Key R&D Program of China
- Shuguang Project
- Innovative research team of high-level local universities in Shanghai
- Major Natural Science Project of the Scientific Research and Innovation Plan of Shanghai Municipal Commission of Education
- Shanghai Research Center for Endocrine and Metabolic Diseases
- Zhejiang Provincial Postdoctoral Science Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Qiu, X., Wang, R. R., Wu, Q. Q., Fu, H., Zhu, S., Chen, W., Wang, W., Chen, H., Ji, X., Zhang, W., Yan, D., Yan, J., Jin, L., Zhang, R., Shi, M., Luo, P., Yang, Y., Wang, Q., Zhang, Z., …, & Meng, Z. X. (2025). BAF60a-dependent chromatin remodeling preserves β cell function and contributes to the therapeutic benefits of GLP-1R agonists. Journal of Clinical Investigation, 135(23). https://doi.org/10.1172/jci177980
Vancouver
Qiu X, Wang RR, Wu QQ, Fu H, Zhu S, Chen W, et al. BAF60a-dependent chromatin remodeling preserves β cell function and contributes to the therapeutic benefits of GLP-1R agonists. Journal of Clinical Investigation. 2025;135(23). doi:10.1172/jci177980
BibTeX
@article{Qiu2025,
author = {Qiu, Xinyuan and Wang, Ruo-Ran and Wu, Qing-Qian and Fu, Hongxing and Zhu, Shuaishuai and Chen, Wei and Wang, Wen and Chen, Haide and Ji, Xiuyu and Zhang, Wenjing and Yan, Dandan and Yan, Jing and Jin, Li and Zhang, Rong and Shi, Mengjie and Luo, Ping and Yang, Yingqing and Wang, Qintao and Zhang, Ziyin and Ding, Wei and Pan, Xiaowen and Li, Chengbin and Liang, Bin and Guo, Guoji and Piao, Hai-Long and Zheng, Min and Yan, Sheng and Zhu, Lingyun and Hu, Cheng and Meng, Zhuo-Xian},
title = {BAF60a-dependent chromatin remodeling preserves β cell function and contributes to the therapeutic benefits of GLP-1R agonists},
journal = {Journal of Clinical Investigation},
year = {2025},
volume = {135},
number = {23},
doi = {10.1172/jci177980}
}
EUVIMED